23 3.1.3 Treatment Phase ........................................................................................................ 24 Abbreviated Title: mRNA-Based, Cancer Vaccine Version Date: January 23, 2019 53.1.4 Dose-Limiting Toxicity ............................................................................................ 24 3.1.5 Phase I – Dose Escalation.........................................................................................